By ANDREW POLLACK
The New York Times
17 December 2004
Is it a wake-up call for the sleeping pill market? With Wednesday's approval of Sepracor's new drug, Lunesta, a taboo in the use of sleeping pills has been broken. Lunesta is the first sleeping pill whose label will not recommend it be taken for only 7 to 10 days.
[ ... Read the full article ... ] (free registration required)